The mitochondrial toxin 3-nitropropionic acid aggravates reserpine-induced oral dyskinesia in rats. 2002

Patricia R V Calvente, and Carlos C S Araujo, and Marcelo Bergamo, and Vanessa C Abilio, and Vânia D'Almeida, and Rosana De A Ribeiro, and Filho Roberto Frussa
Departamento de Farmacologia, São Paulo, SP, Brazil.

The effects of a previous long-term administration of the mitochondrial toxin 3-nitropropionic acid were studied on an animal model of tardive dyskinesia, i.e., the frequency of spontaneous tongue protrusions in rats repeatedly treated with reserpine. 3-Nitropropionic acid (10 or 15 mg/kg i.p., every other day for 17 days) potentiated the increase in tongue-protrusion frequency induced by reserpine (1 mg/kg, s.c., every other day for 3 days) but did not modify reserpine-induced increase in immobility duration and decrease in locomotion frequency. These results support the notion that neurotoxic events are associated with the development of tardive dyskinesia.

UI MeSH Term Description Entries
D008297 Male Males
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D009574 Nitro Compounds Compounds having the nitro group, -NO2, attached to carbon. When attached to nitrogen they are nitramines and attached to oxygen they are NITRATES. Nitrated Compounds
D011422 Propionates Derivatives of propionic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxyethane structure. Propanoate,Propanoic Acid,Propionate,Propanoates,Propanoic Acid Derivatives,Propanoic Acids,Propionic Acid Derivatives,Propionic Acids,Acid, Propanoic,Acids, Propanoic,Acids, Propionic,Derivatives, Propanoic Acid,Derivatives, Propionic Acid
D012110 Reserpine An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use. Raunervil,Raupasil,Rausedil,Rausedyl,Serpasil,Serpivite,V-Serp,V Serp
D003292 Convulsants Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. Convulsant,Convulsant Effect,Convulsant Effects,Effect, Convulsant,Effects, Convulsant
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004409 Dyskinesia, Drug-Induced Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199) Dyskinesia, Medication-Induced,Medication-Induced Dyskinesia,Drug-Induced Dyskinesia,Drug-Induced Dyskinesias,Dyskinesia, Drug Induced,Dyskinesia, Medication Induced,Dyskinesias, Drug-Induced,Dyskinesias, Medication-Induced,Medication Induced Dyskinesia,Medication-Induced Dyskinesias
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Patricia R V Calvente, and Carlos C S Araujo, and Marcelo Bergamo, and Vanessa C Abilio, and Vânia D'Almeida, and Rosana De A Ribeiro, and Filho Roberto Frussa
June 1995, Psychopharmacology,
Patricia R V Calvente, and Carlos C S Araujo, and Marcelo Bergamo, and Vanessa C Abilio, and Vânia D'Almeida, and Rosana De A Ribeiro, and Filho Roberto Frussa
October 1998, European journal of pharmacology,
Patricia R V Calvente, and Carlos C S Araujo, and Marcelo Bergamo, and Vanessa C Abilio, and Vânia D'Almeida, and Rosana De A Ribeiro, and Filho Roberto Frussa
October 2001, The American journal of pathology,
Patricia R V Calvente, and Carlos C S Araujo, and Marcelo Bergamo, and Vanessa C Abilio, and Vânia D'Almeida, and Rosana De A Ribeiro, and Filho Roberto Frussa
January 1993, Journal of neurochemistry,
Patricia R V Calvente, and Carlos C S Araujo, and Marcelo Bergamo, and Vanessa C Abilio, and Vânia D'Almeida, and Rosana De A Ribeiro, and Filho Roberto Frussa
January 2000, Polish journal of pharmacology,
Patricia R V Calvente, and Carlos C S Araujo, and Marcelo Bergamo, and Vanessa C Abilio, and Vânia D'Almeida, and Rosana De A Ribeiro, and Filho Roberto Frussa
January 2010, Neurotoxicology and teratology,
Patricia R V Calvente, and Carlos C S Araujo, and Marcelo Bergamo, and Vanessa C Abilio, and Vânia D'Almeida, and Rosana De A Ribeiro, and Filho Roberto Frussa
November 2004, Neuroscience letters,
Patricia R V Calvente, and Carlos C S Araujo, and Marcelo Bergamo, and Vanessa C Abilio, and Vânia D'Almeida, and Rosana De A Ribeiro, and Filho Roberto Frussa
December 2021, Neurotoxicology,
Patricia R V Calvente, and Carlos C S Araujo, and Marcelo Bergamo, and Vanessa C Abilio, and Vânia D'Almeida, and Rosana De A Ribeiro, and Filho Roberto Frussa
January 2014, ASN neuro,
Patricia R V Calvente, and Carlos C S Araujo, and Marcelo Bergamo, and Vanessa C Abilio, and Vânia D'Almeida, and Rosana De A Ribeiro, and Filho Roberto Frussa
March 2003, Neurobiology of disease,
Copied contents to your clipboard!